MARCHF1
E3 ubiquitin-protein ligase MARCHF1
Also known as: FLJ20668, MARCH-I, MARCH1, MARH1_HUMAN, RNF171
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCQ1
- Gene
- MARCHF1
- Ensembl
- ENSG00000145416
- Chromosome
- 4
- Canonical length
- 289 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Golgi apparatus,Vesicles
OverviewNCBI Gene
MARCH1 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH proteins add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments. MARCH1 downregulates the surface expression of major histocompatibility complex (MHC) class II molecules (see MIM 142880) and other glycoproteins by directing them to the late endosomal/lysosomal compartment (Bartee et al., 2004 [PubMed 14722266]; Thibodeau et al., 2008 [PubMed 18389477]; De Gassart et al., 2008 [PubMed 18305173]).[supplied by OMIM, Mar 2010]
Canonical amino-acid sequenceUniProt
289 residues, UniProt reviewed canonical sequence.
>Q8TCQ1|MARCHF1
1 MLGWCEAIAR NPHRIPNNTR TPEISGDLAD ASQTSTLNEK SPGRSASRSS NISKASSPTT
61 GTAPRSQSRL SVCPSTQDIC RICHCEGDEE SPLITPCRCT GTLRFVHQSC LHQWIKSSDT
121 RCCELCKYDF IMETKLKPLR KWEKLQMTTS ERRKIFCSVT FHVIAITCVV WSLYVLIDRT
181 AEEIKQGNDN GVLEWPFWTK LVVVAIGFTG GLVFMYVQCK VYVQLWRRLK AYNRVIFVQN
241 CPDTAKKLEK NFSCNVNTDI KDAVVVPVPQ TGANSLPSAE GGPPEVVSVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MARCHF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 29 nTPM
- spleen: 24 nTPM
- tonsil: 24 nTPM
- retina: 21 nTPM
- appendix: 20 nTPM
- cerebral cortex: 12 nTPM
Single-cell type
- rod photoreceptor cells: 2,793 nCPM
- cone photoreceptor cells: 2,192 nCPM
- oligodendrocytes: 1,946 nCPM
- oligodendrocyte progenitor cells: 1,401 nCPM
- lactotrophs: 1,336 nCPM
- b-cells: 789 nCPM
Immune cell
- non-classical monocyte: 46 nTPM
- myeloid DC: 44 nTPM
- memory B-cell: 42 nTPM
- classical monocyte: 42 nTPM
- intermediate monocyte: 41 nTPM
- naive B-cell: 36 nTPM
Brain region
- white matter: 36 nTPM
- hypothalamus: 33 nTPM
- cerebral cortex: 27 nTPM
- midbrain: 25 nTPM
- medulla oblongata: 24 nTPM
- basal ganglia: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation of peptide antigen via MHC class II
- immune response
- protein polyubiquitination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MARCHF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MARCHF1 as an antibody target. Whether an autoantibody or antibody against MARCHF1 could matter depends on whether native MARCHF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MARCHF1 is annotated at the cell surface, where native MARCHF1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MARCHF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...